It researches, develops, produces and markets innovative biotechnological products, focused on the agricultural sector and in the field of hormone-sensitive tumor therapies.
Its main product is the recombinant vaccine for the control of ticks in cattle Gavac®. Other of its products are Porvac® : a vaccine against classical swine fever, and Hebernem®, an ecological bionematicide, effective in the control of nematodes, especially in growing houses. protected vegetables, which also attack outdoor plantations.
Generate, develop, produce and commercialize biotechnological products for the agricultural sphere, to contribute to the economic, social and environmental development of Cuba, based on a quality management system that guarantees customer satisfaction.
To be a leading institution, of national and international prestige, in agricultural biotechnology, achieving full customer satisfaction.
The CIGB of Camagüey was inaugurated by Commander-in-Chief Fidel Castro Ruz on July 25, 1989. Due to the cattle-raising nature of the province of Camagüey, its projects are mainly directed to the agricultural sphere. The first product that the center developed was a recombinant vaccine against colibacillosis that affected pigs and caused great economic losses. The Gavac® tick vaccine has been our leading product for almost 20 years. It has been exported to several Latin American countries.
Director of CIGB Camagüey
Development of new bioproducts for the control of nematodes